CLINICAL_TRIALS ClinicalTrials.gov record update

Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox® ) During Consolidation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00866918
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:56.655068+00:00
Published At: 2017-04-04T00:00:00+00:00
Record Updated At: 2022-10-25
Results Posted At: 2017-04-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Childhood Acute Promyelocytic Leukemia With PML-RARA", "Myeloid Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-10-25"
protocolSection.identificationModule.nctId: "NCT00866918"
protocolSection.identificationModule.officialTitle: "Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox\u00ae ) During Consolidation"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.